Jan 30 (Reuters) - The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' (VRTX.O), opens new tab drug to treat acute pain, the health regulator said on Thursday, offering a ...

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices giant had some weakness in recent years amid disappointing trends from ...

Shares of Medtronic are benefiting from an improved earnings growth outlook. The company is capturing strong demand for its new lineup of high-tech medical devices. The stock trades at just 16 ...

Square parent Block and Shopify are trading around buy points despite market volatility around big earnings and Trump tariffs ...

1 Day VRTX -0.71% DJIA 0.38% S&P 500 0.53% Health Care/Life Sciences 0.19% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Hydro One Limited is a key player in Ontario's electricity sector, focusing on the transmission and distribution of electricity. It boasts an extensive network, with around 30,000 kilometers of ...

After hours: 7:57:32 pm GMT-5 ...

At close: January 28 at 4:00:02 PM EST ...